The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis
- 1 October 2022
- journal article
- research article
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 29 (5) , 2460-2470
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Incidence of Caffeine in Serum of Patients Undergoing Dipyridamole Myocardial Perfusion Stress Test by an Intensive Versus Routine Caffeine History ScreeningThe American Journal of Cardiology, 2010
- Refractory ventricular tachycardia secondary to cardiac sarcoid: Electrophysiologic characteristics, mapping, and ablationHeart Rhythm, 2006
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosisThe American Journal of Cardiology, 2005
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the HeartCirculation, 2002
- Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in JapanActa Pathologica Japonica, 1993
- Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia deviceJACC, 1991
- Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosisThe American Journal of Medicine, 1988
- Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.Circulation, 1978